Adjuncts in the IVF laboratory: where is the evidence for 'add-on'interventions?

J Harper, E Jackson, K Sermon, RJ Aitken… - Human …, 2017 - academic.oup.com
Globally, IVF patients are routinely offered and charged for a selection of adjunct treatments
and tests or 'add-ons' that they are told may improve their chance of a live birth, despite there …

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction

HE Nagels, JR Rishworth… - Cochrane Database …, 2015 - cochranelibrary.com
Background Infertility is a condition affecting 10% to 15% of couples of reproductive age. It is
generally defined as" the failure to achieve a clinical pregnancy after 12 months or more of …

[HTML][HTML] Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons

J Wilkinson, P Malpas, K Hammarberg, PM Tsigdinos… - Fertility and sterility, 2019 - Elsevier
Add-on treatments are the new black. They are provided (most frequently, sold) to patients
undergoing in vitro fertilization on the premise that they will improve the chances of having a …

[HTML][HTML] Immune modulation treatments—where is the evidence?

MM Hviid, N Macklon - Fertility and Sterility, 2017 - Elsevier
While advances in assisted reproductive techniques have been substantial, failure of the
apparently viable embryo to implant remains a source of distress and frustration to patients …

Best practices for controlled ovarian stimulation in in vitro fertilization

ES Jungheim, MF Meyer… - Seminars in reproductive …, 2015 - thieme-connect.com
As applications for IVF have expanded over the years, so too have approaches to controlled
ovarian stimulation (COS) for IVF. With this expansion and improved knowledge of basic …

Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis

KN Keane, JL Yovich, A Hamidi, PM Hinchliffe… - BMJ open, 2017 - bmjopen.bmj.com
Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

Determining diagnostic criteria and cause of recurrent implantation failure

Y Cakiroglu, B Tiras - Current opinion in obstetrics and …, 2020 - journals.lww.com
Determining diagnostic criteria and cause of recurrent impla... : Current Opinion in Obstetrics
and Gynecology Determining diagnostic criteria and cause of recurrent implantation failure …

Classic and global hemostasis testing in pregnancy and during pregnancy complications

FI Ataullakhanov, EM Koltsova… - … in Thrombosis and …, 2016 - thieme-connect.com
Pregnancy is associated with a significant procoagulant shift in the hemostatic system
balance as well as other metabolic changes. Pregnancy can thereby provoke manifestation …

[HTML][HTML] New therapeutic protocol for improvement of endometrial receptivity (PRIMER) for patients with recurrent implantation failure (RIF)–A pilot study

F Dieamant, LD Vagnini, CG Petersen… - JBRA assisted …, 2019 - ncbi.nlm.nih.gov
Objective: To evaluate whether or not one should use a new Protocol for Endometrial
Receptivity Improvement (PRIMER) based on platelet-rich plasma (PRP) and granulocyte …

[HTML][HTML] Evidence for the effectiveness of immunologic therapies in women with subfertility and/or undergoing assisted reproduction

P Melo, T Thornton, A Coomarasamy, I Granne - Fertility and Sterility, 2022 - Elsevier
Implantation is a critical step in the establishment of a successful pregnancy, depending on
a complex immune-endocrine dialogue between the developing embryo and maternal …